Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1993;2(7):S51–S56. doi: 10.1155/S0962935193000766

Amelioration of popolysaccharide-induced sepsis in rats by free and esterified carnitine

Linda L Gallo 1,✉, Yan Tian 1, Zaven Orfalian 2, Gary Fiskum 1,3
PMCID: PMC2365443  PMID: 18475572

Abstract

The purpose of this study was to determine if free or esterified carnitine could alter fatty acid metabolism and ameliorate sepsis in lipopolysaccharide (LPS)-treated rats. Throughout a 96 h observation post-LPS, i.p. administration of both markedly reduced illness and accelerated recovery. Carnitine prevented the acute LPS-induced rise in serum triglycerides (45 ± 6, 59 ± 5 vs. 83 ± 8 mg/ml, p < 0.001), respectively. This difference was accompanied by a significant increase in liver lipogenesis in LPS controls compared to both carnitines and normal rats (6.1 ± 0.3 vs. 3.9 ± 0.5, 4.3 ± 0.5, and 1.8 ± 0.4 μmol/h, respectively, p < 0.04). Compared to normal rats, total liver carnitine was significantly elevated in LPS controls and even higher in the carnitine groups (357 ± 40 vs. 736 ± 38, 796 ± 79, and 1081 ± 21 nmol/g). The data suggest that carnitines may be of therapeutic value in sepsis treatment and one action may be to partition fatty acids from esterification to oxidation.

Full Text

The Full Text of this article is available as a PDF (544.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brass E. P., Hoppel C. L. Effect of carnitine on mitochondrial oxidation of palmitoylearnitine. Biochem J. 1980 May 15;188(2):451–458. doi: 10.1042/bj1880451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brass E. P., Hoppel C. L. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J. 1980 Sep 15;190(3):495–504. doi: 10.1042/bj1900495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bremer J. Carnitine--metabolism and functions. Physiol Rev. 1983 Oct;63(4):1420–1480. doi: 10.1152/physrev.1983.63.4.1420. [DOI] [PubMed] [Google Scholar]
  4. Christiansen R. Z. Regulation of palmitate metabolism by carnitine and glucagon in hepatocytes isolated from fasted and carbohydrate refed rats. Biochim Biophys Acta. 1977 Aug 24;488(2):249–262. doi: 10.1016/0005-2760(77)90182-5. [DOI] [PubMed] [Google Scholar]
  5. Feingold K. R., Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987 Jul;80(1):184–190. doi: 10.1172/JCI113046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gallin J. I., Kaye D., O'Leary W. M. Serum lipids in infection. N Engl J Med. 1969 Nov 13;281(20):1081–1086. doi: 10.1056/NEJM196911132812001. [DOI] [PubMed] [Google Scholar]
  7. Ide T., Ontko J. A. Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver. J Biol Chem. 1981 Oct 25;256(20):10247–10255. [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Marchuk J. B., Finley R. J., Groves A. C., Wolfe L. I., Holliday R. L., Duff J. H. Catabolic hormones and substrate patterns in septic patients. J Surg Res. 1977 Sep;23(3):177–182. doi: 10.1016/0022-4804(77)90018-x. [DOI] [PubMed] [Google Scholar]
  10. McGarry J. D., Foster D. W. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res. 1976 May;17(3):277–281. [PubMed] [Google Scholar]
  11. McGarry J. D., Robles-Valdes C., Foster D. W. Role of carnitine in hepatic ketogenesis. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4385–4388. doi: 10.1073/pnas.72.11.4385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murphy A. N., Kelleher J. K., Fiskum G. Submicromolar Ca2+ regulates phosphorylating respiration by normal rat liver and AS-30D hepatoma mitochondria by different mechanisms. J Biol Chem. 1990 Jun 25;265(18):10527–10534. [PubMed] [Google Scholar]
  13. Rosenthal R. E., Williams R., Bogaert Y. E., Getson P. R., Fiskum G. Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke. 1992 Sep;23(9):1312–1318. doi: 10.1161/01.str.23.9.1312. [DOI] [PubMed] [Google Scholar]
  14. Takeyama N., Itoh Y., Kitazawa Y., Tanaka T. Altered hepatic mitochondrial fatty acid oxidation and ketogenesis in endotoxic rats. Am J Physiol. 1990 Oct;259(4 Pt 1):E498–E505. doi: 10.1152/ajpendo.1990.259.4.E498. [DOI] [PubMed] [Google Scholar]
  15. Waber L. J., Valle D., Neill C., DiMauro S., Shug A. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr. 1982 Nov;101(5):700–705. doi: 10.1016/s0022-3476(82)80294-1. [DOI] [PubMed] [Google Scholar]
  16. Worthley L. I., Fishlock R. C., Snoswell A. M. Carnitine deficiency with hyperbilirubinemia, generalized skeletal muscle weakness and reactive hypoglycemia in a patient on long-term total parenteral nutrition: treatment with intravenous L-carnitine. JPEN J Parenter Enteral Nutr. 1983 Mar-Apr;7(2):176–180. doi: 10.1177/0148607183007002176. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES